Response to Harms et al

J Invest Dermatol. 2022 Nov;142(11):3122-3123. doi: 10.1016/j.jid.2022.04.012. Epub 2022 Apr 30.

Authors

Michael A Marchetti¹, Nicholas R Kurtansky², Stephen W Dusza², Ashfaq A Marghoob², Veronica M Rotemberg², Allan C Halpern²

Affiliations

¹ Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: marchetm@mskcc.org.
² Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

PMID: 35500639
DOI: 10.1016/j.jid.2022.04.012

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States